193551-21-2COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1ZQUSFAUAYSEREK-UHFFFAOYSA-NSB-239063 is a member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of cyclohexanols, a member of imidazoles, an aromatic ether, a secondary alcohol, a member of pyrimidines and a member of monofluorobenzenes.
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
VerwendenSB 239063 has been used to determine the roles of c-Jun N-terminal kinase (JNK), p38 MAP kinase, and extracellular signal regulated protein kinase (ERK)/p42/p44 mitogen activated protein kinase (MAPK) on the viability and apoptosis of cardiomyocytes under glutathione S-transferase (GST) inhibition. It has also been used in neuron-microglia conditioned media (CM) experiments and pharmacokinetics.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…
193551-21-2DTXSID90274455CHEMBL256835、CHEMBL4166018、CHEMBL97162CHEBI:90681DefinitionChEBI: A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.